US Patent Issued to Jiangsu Hengrui Pharmaceuticals on March 31 for "Fused imidazole derivatives, preparation method and medicinal use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,081, issued on March 31, was assigned to Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Lianyungang, China).

"Fused imidazole derivatives, preparation method and medicinal use thereof" was invented by Fanglong Yang (Shanghai), Qian Yang (Shanghai), Feng He (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to fused imidazole derivatives, preparation methods and medical use thereof. Specifically, the present disclosure relates to a fused imidazole derivative represented by the general formula (I), the preparation method thereof, and the pharmaceutical composition containing the same, as well...